A human memory T cell subset with stem cell–like properties

Gattinoni, Luca, Lugli, Enrico, Ji, Yun, Pos, Zoltan, Paulos, Chrystal M, Quigley, Máire F, Almeida, Jorge R, Gostick, Emma +9 more·2011·Nature Medicine

Cited by (1,001)

Items 301–400 of 1,001

  1. Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors
    Hannah Karlsson, Emma Svensson, Camilla Gigg, Malin Jarvius, Ulla Olsson‐Strömberg, Barbara Savoldo, Gianpietro Dotti, Angelica Loskog · 2015 · PLoS ONE
  2. Immunological memories of the bone marrow
    Hyun‐Dong Chang, Koji Tokoyoda, Andreas Radbruch · 2018 · Immunological Reviews
  3. The Single-Cell Phenotypic Identity of Human CD8+ and CD4+ T Cells
    Jolanda Brummelman, Karolina Pilipow, Enrico Lugli · 2018 · International review of cytology
  4. Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic
    Connie P.M. Duong, Carmen S. M. Yong, Michael H. Kershaw, Clare Y. Slaney, Phillip Kevin Darcy · 2015 · Molecular Immunology
  5. Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines
    Connor J. Dwyer, Hannah M. Knochelmann, Aubrey S. Smith, Megan M. Wyatt, Guillermo O. Rangel Rivera, Dimitrios C. Arhontoulis, Eric Bartee, Zihai Li, Mark P. Rubinstein, Chrystal Mary Paulos · 2019 · Frontiers in Immunology
  6. Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies
    Daniela G.M. Tantalo, Amanda J. Oliver, Bianca von Scheidt, Aaron J Harrison, Scott N. Mueller, Michael H. Kershaw, Clare Y. Slaney · 2021 · Journal for ImmunoTherapy of Cancer
  7. The Th17 Lineage: From Barrier Surfaces Homeostasis to Autoimmunity, Cancer, and HIV-1 Pathogenesis
    Vanessa Sue Wacleche, ALAN L. LANDAY, Jean‐Pierre Routy, Petronela Ancuța · 2017 · Viruses
  8. CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies
    Hong Qin, Zhenyuan Dong, Xiuli Wang, Wesley A. Cheng, Feng Wen, Weili Xue, Han Sun, Miriam Walter, Guo‐Wei Wei, Diane Lynne Smith et al. · 2019 · Science Translational Medicine
  9. Stem, Effector, and Hybrid States of Memory CD8+ T Cells
    Enrico Lugli, Giovanni Galletti, Shannon Kathryn Boi, Ben Youngblood · 2019 · Trends in Immunology
  10. Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
    Xueting Xia, Zongxin Yang, Qisi Lu, Zhenyun Liu, Lei Wang, Jinwen Du, Yuhua Li, Dong‐Hua Yang, Shaojie Wu · 2024 · Molecular Cancer
  11. Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
    Painter, Mark M., Johnston, Timothy S., Lundgreen, Kendall A., Santos, Jefferson J. S., Qin, Juliana S., Goel, Rishi R., Apostolidis, Sokratis A., Mathew, Divij, Fulmer, Bria, Williams, Justine C. et al. · 2023 · Nature Immunology
  12. Lowest numbers of primary CD8+ T cells can reconstitute protective immunity upon adoptive immunotherapy
    Christian Stemberger, Patricia Graef, Marcus Odendahl, Julia Albrecht, Georg Dössinger, Florian Anderl, Veit R. Buchholz, Georg Gasteiger, Matthias Schiemann, Götz Ulrich Grigoleit et al. · 2014 · Blood
  13. An evolutionary perspective on the systems of adaptive immunity
    Viktor Müller, Rob J. de Boer, Sebastian Bonhoeffer, Eörs Szathmáry · 2017 · Biological reviews/Biological reviews of the Cambridge Philosophical Society
  14. Tissue Resident CD8 Memory T Cell Responses in Cancer and Autoimmunity
    Aleksey K. Molodtsov, M. Turk · 2018 · Frontiers in Immunology
  15. Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery
    Ramya Sivakumar, Marina Chan, Jiye Stella Shin, Nao Nishida‐Aoki, Heidi L. Kenerson, Olivier Elemento, Himisha Beltran, Raymond S. W. Yeung, Taranjit S. Gujral · 2019 · OncoImmunology
  16. CD19-CAR T cells undergo exhaustion DNA methylation programming in patients with acute lymphoblastic leukemia
    Caitlin C. Zebley, Charmaine Brown, Mi Tian, Yiping Fan, Shanta Alli, Shannon Kathryn Boi, Giovanni Galletti, Enrico Lugli, Deanna M. Langfitt, Jean‐Yves Métais et al. · 2021 · Cell Reports
  17. Tumor-Infiltrating Lymphocytes in Melanoma
    Sylvia Y. Lee, Kim Allyson Margolin · 2012 · Current Oncology Reports
  18. Lymphocyte maintenance during healthy aging requires no substantial alterations in cellular turnover
    Westera, Liset, van Hoeven, Vera, Drylewicz, Julia, Spierenburg, Gerrit, van Velzen, Jeroen F., de Boer, Rob J., Tesselaar, Kiki, Borghans, José A. M. · 2015 · Aging Cell
  19. The Pharmacology of T Cell Therapies
    Michael C. Milone, Vijay G. Bhoj · 2018 · Molecular Therapy — Methods & Clinical Development
  20. CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
    Sarah Marie Larson, Christopher M. Walthers, Brenda Ji, Sanaz Noelle Ghafouri, Jacob Naparstek, Jacqueline Trent, Jia Ming Chen, Mobina Roshandell, Caitlin M. Harris, Mobina Khericha et al. · 2022 · Cancer Discovery
  21. Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia
    Kohei Thi Hosokawa, Pawel J. Muranski, Xingmin Feng, Danielle Michelle Townsley, Baoying Liu, Jared E. Knickelbein, Keyvan Keyvanfar, Bogdan Dumitriu, Sawa Ito, Sachiko Kajigaya et al. · 2016 · The Journal of Immunology
  22. Neonatal thymectomy reveals differentiation and plasticity within human naive T cells
    van den Broek, Theo, Delemarre, Eveline M., Janssen, Willemijn J.M., Nievelstein, Rutger A.J., Broen, Jasper C., Tesselaar, Kiki, Borghans, Jose A.M., Nieuwenhuis, Edward E.S., Prakken, Berent J., Mokry, Michal et al. · 2016 · Journal of Clinical Investigation
  23. Notch-mediated conversion of activated T cells into stem cell memory-like T cells for adoptive immunotherapy
    Taisuke Kondo, Rimpei Morita, Yuumi Okuzono, Hiroko Nakatsukasa, Takashi Sekiya, Shunsuke Chikuma, Takashi Shichita, Mitsuhiro Kanamori, Masato Kubo, Keiko Koga et al. · 2017 · Nature Communications
  24. Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence
    Stefanie R. Bailey, Michelle Hase Nelson, Kinga Majchrzak, Jacob S. Bowers, Megan M. Wyatt, Aubrey S. Smith, Lillian R. Neal, Keisuke Shirai, Carmine Carpenito, Carl H. June et al. · 2017 · Nature Communications
  25. TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals
    Francesco Manfredi, Beatrice Claudia Cianciotti, Alessia Potenza, Elena Tassi, Maddalena Noviello, Andrea Biondi, Fabio Ciceri, Chiara Bonini, Eliana Ruggiero · 2020 · Frontiers in Immunology
  26. An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics
    Shaobo Wang, Qiong Zhang, Hui Hui, Kriti Agrawal, Maile Karris, Tariq M. Rana · 2020 · Emerging Microbes & Infections
  27. Novel strategies exploiting interleukin-12 in cancer immunotherapy.
    Assunta Cirella, Carlos Luri-Rey, C. D. Di Trani, Á. Teijeira, Irene Olivera, Elixabet Bolaños, E. Castañón, B. Palencia, D. Brocco, Myriam Fernández-Sendin et al. · 2022 · Pharmacology and Therapeutics
  28. Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients
    Jean‐Marc Hoffmann, Maria‐Luisa Schubert, Lei Wang, Angela G. Hückelhoven, Leopold Sellner, Sophia Stock, Anita Schmitt, Christian Kleist, Ulrike Gern, Angelica Loskog et al. · 2018 · Frontiers in Immunology
  29. The CD4-centered universe of human T cell subsets
    Jens Geginat, Moira Paroni, Federica Facciotti, Paola Gruarin, Ilko Kastirr, Flavio Caprioli, Massimiliano Pagani, Sergio Abrignani · 2013 · Seminars in Immunology
  30. A second chance for telomerase reverse transcriptase in anticancer immunotherapy
    Maurizio Zanetti · 2016 · Nature Reviews Clinical Oncology
  31. Memory T-Cell Heterogeneity and Terminology
    Yuki Muroyama, E. John Wherry · 2021 · Cold Spring Harbor Perspectives in Biology
  32. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4 + T cells, and disease progression
    Daniel T. Claiborne, Jessica L. Prince, Eileen P. Scully, Gladys N. Macharia, Luca Micci, Benton Lawson, Jakub T. Kopycinski, Martin J. Deymier, Thomas H. Vanderford, Krystelle Nganou‐Makamdop et al. · 2015 · Proceedings of the National Academy of Sciences
  33. Metabolic reprograming of anti-tumor immunity
    Madhusudhanan Sukumar, Rigel J. Kishton, Nicholas P. Restifo · 2017 · Current Opinion in Immunology
  34. Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy
    Ryan Z. Urak, Miriam Walter, Laura Lim, ChingLam W. Wong, Lihua Elizabeth Budde, Sandra H. Thomas, Stephen J. Forman, Xiuli Wang · 2017 · Journal for ImmunoTherapy of Cancer
  35. The architectural design of CD8+ T cell responses in acute and chronic infection: Parallel structures with divergent fates
    H. Kay Chung, Bryan McDonald, Susan M. Kaech · 2021 · The Journal of Experimental Medicine
  36. Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity
    Emily S.J. Edwards, Julia Bier, Theresa S. Cole, Melanie Wong, Peter S. Hsu, Lucinda J. Berglund, Kaan Boztuǧ, Anthony Lau, Emma Gostick D, David A. Price et al. · 2018 · Journal of Allergy and Clinical Immunology
  37. T Cell Fitness and Autologous CAR T Cell Therapy in Haematologic Malignancy
    Palak H. Mehta, Salvatore Fiorenza, Rachel M. Koldej, Anthony Jaworowski, David S. Ritchie, Kylie M. Quinn · 2021 · Frontiers in Immunology
  38. EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors
    Li, Dan, Guo, Xianling, Yang, Kun, Yang, Yuening, Zhou, Weilin, Huang, Yong, Liang, Xiao, Su, Jinhua, Jiang, Lin, Li, Jing et al. · 2023 · Science Advances
  39. Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy
    Hong Sun, Dhohyung Kim, Xiaodong Li, Maja Kiselinova, Zhengyu Ouyang, Linos Vandekerckhove, Hong Shang, Eric S. Rosenberg, Xu G. Yu, Mathias D. Lichterfeld · 2015 · Journal of Virology
  40. EGFR‐targeted CAR‐T cells are potent and specific in suppressing triple‐negative breast cancer both in vitro and in vivo
    Lin Xia, Zaozao Zheng, Jun‐yi Liu, Yu‐jie Chen, Jian‐cheng Ding, Ningshao Xia, Wenxin Luo, Wen Liu · 2020 · Clinical & Translational Immunology
  41. Automated manufacture of autologous CD19 CAR-T cells for treatment of non-hodgkin lymphoma
    Jackson, Zachary, Roe, Anne, Sharma, Ashish Arunkumar, Lopes, Filipa Blasco Tavares Pereira, Talla, Aarthi, Kleinsorge-Block, Sarah, Zamborsky, Kayla, Schiavone, Jennifer, Manjappa, Shivaprasad, Schauner, Robert et al. · 2020 · Frontiers in Immunology
  42. Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy
    Tae Gun Kang, Xin Lan, Mi Tian, Hongfeng Chen, Shanta Alli, Song-Eun Lim, Sheetal Bhatara, Anoop Babu Vasandan, Grace Ward, Sofía Bentivegna et al. · 2024 · Science
  43. Adoptive T-cell therapy for cancer: the era of engineered T cells
    Bonini, Chiara, Mondino, Anna · 2015 · European Journal of Immunology
  44. Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective
    Isabelle Rivière, Michel Sadelain · 2017 · Molecular Therapy
  45. CAR-T cell therapy: a potential new strategy against prostate cancer
    Giuseppe Schepisi, Maria Concetta Cursano, Chiara Casadei, Cecilia Menna, Amelia Altavilla, Cristian Lolli, Claudio Cerchione, Giovanni Paganelli, Daniele Santini, Giuseppe Tonini et al. · 2019 · Journal for ImmunoTherapy of Cancer
  46. Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapy
    David M. Barrett, Nathan Singh, Xiaojun Liu, Shuguang Jiang, Carl H. June, Stephan A. Grupp, Yangbing Zhao · 2014 · Cytotherapy
  47. Lingering effects of chemotherapy on mature T cells impair proliferation
    Rajat Kumar Das, Roddy S. O’Connor, Stephan A. Grupp, David Maxwell Barrett · 2020 · Blood Advances
  48. Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity
    Yajing Qiu, Yapeng Su, Ermei Xie, Hongcheng Cheng, Jing Du, Yue Xu, Xiaoli Pan, Zhe Wang, Daniel G. Chen, Zhu Hong et al. · 2024 · Cancer Cell
  49. Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails
    Shicheng Yang, Yun Ji, Luca Gattinoni, Ling Zhang, Zhiya Yu, Nicholas P. Restifo, Steven A. Rosenberg, Richard A. Morgan · 2012 · Cancer Immunology Immunotherapy
  50. A highly soluble Sleeping Beauty transposase improves control of gene insertion
    Irma Querques, Andreas Mades, Cecilia Zuliani, Csaba Miskey, Miriam Alb, Esther Grueso, Markus Machwirth, Tobias Rausch, Hermann Einsele, Zoltán Ivics et al. · 2019 · Nature Biotechnology
  51. Graded expression of the chemokine receptor CX3CR1 marks differentiation states of human and murine T cells and enables cross-species interpretation
    Anthonie J. Zwijnenburg, Jyoti Pokharel, Renata Varnaitė, Wenning Zheng, Elena Hoffer, Iman Shryki, Natalia R Comet, Marcus Ehrström, Sara Gredmark‐Russ, Liv Eidsmo et al. · 2023 · Immunity
  52. Early predictive factors of failure in autologous CAR T-cell manufacturing and/or efficacy in hematologic malignancies
    Clémentine Baguet, Jérôme Larghero, Miryam Mebarki · 2023 · Blood Advances
  53. Strategies to enhance CAR-T persistence
    Liu, Yue, An, Lingna, Huang, Ruihao, Xiong, Jingkang, Yang, Haoyu, Wang, Xiaoqi, Zhang, Xi · 2022 · Biomarker Research
  54. The NOTCH–FOXM1 Axis Plays a Key Role in Mitochondrial Biogenesis in the Induction of Human Stem Cell Memory–like CAR-T Cells
    Taisuke Kondo, Makoto Ando, Nao Nagai, Wataru Tomisato, Tanakorn Srirat, Binbin Liu, Setsuko Mise‐Omata, Mari Ikeda, Shunsuke Chikuma, Hiroshi Nishimasu et al. · 2019 · Cancer Research
  55. Single‐Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Esophageal Squamous Cell Carcinoma
    Yongxu Jia, Baifeng Zhang, Chunyang Zhang, Dora Lai‐Wan Kwong, Zhiwei Chang, Shanshan Li, Zehua Wang, Huiqiong Han, Jing Li, Yali Zhong et al. · 2023 · Advanced Science
  56. Phenotypic and functional differentiation of porcine αβ T cells: current knowledge and available tools.
    W. Gerner, Stephanie C. Talker, H. Koinig, Corinna Sedlak, Kerstin H. Mair, A. Saalmüller · 2015 · Molecular Immunology
  57. Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy
    Fei Yi, Nicholas Frazzette, Anthony C. Cruz, Christopher Austin Klebanoff, Richard M. Siegel · 2018 · Trends in Molecular Medicine
  58. Thymus involution sets the clock of the aging T-cell landscape: Implications for declined immunity and tissue repair
    Yehezqel Elyahu, Alon Monsonego · 2020 · Ageing Research Reviews
  59. PD-1 and TIGIT downregulation distinctly affect the effector and early memory phenotypes of CD19-targeting CAR T cells
    Young-Ho Lee, Hyeong Ji Lee, Hyung Cheol Kim, Yujean Lee, Su Kyung Nam, Cedric Hupperetz, Jennifer S. Y. Ma, Xinxin Wang, Oded Singer, Won Seog Kim et al. · 2021 · Molecular Therapy
  60. Applying a clinical lens to animal models of CAR-T cell therapies
    Brynn B. Duncan, Cynthia E. Dunbar, Kazusa Ishii · 2022 · Molecular Therapy — Methods & Clinical Development
  61. Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India
    Palani, Hamenth Kumar, Arunachalam, Arun Kumar, Yasar, Mohammed, Venkatraman, Arvind, Kulkarni, Uday, Lionel, Sharon Anbumalar, Selvarajan, Sushil, Korula, Anu, Abraham, Aby, George, Biju et al. · 2023 · Bone Marrow Transplantation
  62. Inhibitory signaling sustains a distinct early memory CD8 + T cell precursor that is resistant to DNA damage
    Jonathan B. Johnnidis, Yuki Muroyama, Shin Foong Ngiow, Zeyu Chen, Sasikanth Manne, Zhangying Cai, Shufei Song, Jesse M. Platt, Jason M. Schenkel, Mohamed S. Abdel-Hakeem et al. · 2021 · Science Immunology
  63. Chimeric antigen receptors: driving immunology towards synthetic biology
    Michel Sadelain · 2016 · Current Opinion in Immunology
  64. Strong homeostatic TCR signals induce formation of self‐tolerant virtual memory CD8 T cells
    Ales Drobek, Alena Moudrá, Daniel L. Mueller, Martina Huranová, Veronika Horková, Michaela Přibíková, Robert Ivánek, Susanne G. Oberle, Dietmar Zehn, Kathy D. McCoy et al. · 2018 · The EMBO Journal
  65. Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy
    Sara De Biasi, Lara Gibellini, Domenico Lo Tartaro, Simone Puccio, Claudio Rabacchi, Emilia Maria Cristina Mazza, Jolanda Brummelman, Brandon Williams, Kelly A. Kaihara, Mattia Forcato et al. · 2021 · Nature Communications
  66. Optimization of metabolism to improve efficacy during CAR-T cell manufacturing
    Meng Zhang, Xin Kinson Jin, Rui Sun, Xia Xiong, Jiaxi Wang, Danni Xie, Mingfeng Zhao · 2021 · Journal of Translational Medicine
  67. The naive T-cell receptor repertoire has an extremely broad distribution of clone sizes
    Peter C. de Greef, Theres Oakes, Bram Gerritsen, Mazlina Ismail, James Heather, Rutger Hermsen, Benny Chain, Rob J. de Boer · 2020 · eLife
  68. Current status of chimeric antigen receptor therapy for haematological malignancies
    Shannon L. Maude, David Maxwell Barrett · 2015 · British Journal of Haematology
  69. A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy
    C. Alvarez-Fernández, Laura Escribà-García, Sílvia Vidal, Jorge Sierra, Javier Briones · 2016 · Journal of Translational Medicine
  70. Continuous Effector CD8 + T Cell Production in a Controlled Persistent Infection Is Sustained by a Proliferative Intermediate Population
    Hunghao Chu, Shiao Wei Chan, John Paul Gosling, Nicolas Blanchard, Alexandra Tsitsiklis, Grant Lythe, Nilabh Shastri, Carmen Molina-Parı́s, Ellen A. Robey · 2016 · Immunity
  71. Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer
    Hee Jin Lee, Young‐Ae Kim, Chan Kyu Sim, Sun‐Hee Heo, In Hye Song, Hye Seon Park, Suk Young Park, Won Seon Bang, In Ah Park, Miseon Lee et al. · 2017 · Oncotarget
  72. PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8+ T Cells
    Jacob S. Bowers, Kinga Majchrzak, Michelle Hase Nelson, Bülent Arman Aksoy, Megan M. Wyatt, Aubrey S. Smith, Stefanie R. Bailey, Lillian R. Neal, Jeff Hammerbacher, Chrystal Mary Paulos · 2017 · Frontiers in Immunology
  73. Memory T Cells in Pregnancy
    Tom E. C. Kieffer, Anne Laskewitz, Sicco A. Scherjon, Marijke M. Faas, Jelmer Riemer Prins · 2019 · Frontiers in Immunology
  74. Control of memory CD8+ T cell longevity and effector functions by IL-15
    Jeffrey C. Nolz, Martin J. Richer · 2019 · Molecular Immunology
  75. Cellular and molecular waypoints along the path of T cell exhaustion
    Xin Lan, Caitlin C. Zebley, Ben Youngblood · 2023 · Science Immunology
  76. Stem memory T cells (TSCM)—their role in cancer and HIV immunotherapies
    Jacqueline K. Flynn, Paul R. Gorry · 2014 · Clinical & Translational Immunology
  77. The use of endogenous T cells for adoptive transfer
    Cassian Yee · 2013 · Immunological Reviews
  78. Abacavir-Reactive Memory T Cells Are Present in Drug Naïve Individuals
    Andrew Lucas, Michaela Lucas, Anette Strhyn, Niamh M. Keane, E. McKinnon, Rebecca K. Pavlos, Ellen M Moran, Viola Meyer-Pannwitt, Silvana Gaudieri, Lloyd J. A. D'Orsogna et al. · 2015 · PLoS ONE
  79. Human Stem Cell-like Memory T Cells Are Maintained in a State of Dynamic Flux
    Raya Ahmed, Lauréline Roger, Pedro Costa del Amo, Kelly L. Miners, Rhiannon E. Jones, Lies Boelen, Tinhinane Fali, Marjet Elemans, Yan Zhang, Victor Appay et al. · 2016 · Cell Reports
  80. Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies
    Yuru Nie, Weiqing Lu, Daiyu Chen, Huilin Tu, Zhenling Guo, Xuan Zhou, Meifang Li, Sanfang Tu, Yuhua Li · 2020 · Biomarker Research
  81. Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors
    Emmanuel Donnadieu, Loı̈c Dupré, Lia Gonçalves Pinho, Vinı́cius Cotta-de-Almeida · 2020 · Journal of Leukocyte Biology
  82. Ibrutinib for improved chimeric antigen receptor T‐cell production for chronic lymphocytic leukemia patients
    Fuli Fan, Hyeon Joo Yoo, Sophia Stock, Lei Wang, Yibin Liu, Maria‐Luisa Schubert, Sanmei Wang, Brigitte Neuber, Angela Hückelhoven‐Krauss, Ulrike Gern et al. · 2020 · International Journal of Cancer
  83. miR-143 Regulates Memory T Cell Differentiation by Reprogramming T Cell Metabolism
    Tengfei Zhang, Zhen Zhang, Feng Li, Yu Ping, Guohui Qin, Chaoqi Zhang, Yi Zhang · 2018 · The Journal of Immunology
  84. Hypoxia and antitumor CD8+ T cells: An incompatible alliance?
    Romain Vuillefroy de Silly, Pierre‐Yves Dietrich, Paul R. Walker · 2016 · OncoImmunology
  85. Nonapoptotic functions of Fas/ CD 95 in the immune response
    Jean‐Philippe Guégan, Patrick Legembre · 2017 · FEBS Journal
  86. Co-Expression of IL-7 Improves NKG2D-Based CAR T Cell Therapy on Prostate Cancer by Enhancing the Expansion and Inhibiting the Apoptosis and Exhaustion
    Cong He, Ying Yin Zhou, Zhenlong Li, Muhammad Asad Farooq, Iqra Ajmal, Hongmei Zhang, Li Zhang, Lei Tao, Jie Yao, Bing Du et al. · 2020 · Cancers
  87. Targeting Cancer Stem Cell Redox Metabolism to Enhance Therapy Responses
    Ming Luo, Max S. Wicha · 2018 · Seminars in Radiation Oncology
  88. Detection and Characterization of CD8+ Autoreactive Memory Stem T Cells in Patients With Type 1 Diabetes
    Debora Vignali, Elisa Cantarelli, Carlotta Bordignon, Adriana Canu, Antonio Citro, Andrea Annoni, Lorenzo Piemonti, Paolo Monti · 2018 · Diabetes
  89. Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade
    Douglas C. Palmer, Beau R. Webber, Yogin K. Patel, Matthew J. Johnson, Christine M. Kariya, Walker S. Lahr, Maria R. Parkhurst, Jared J. Gartner, Todd D. Prickett, Frank J. Lowery et al. · 2022 · Med
  90. Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination
    Anke Redeker, Ramon Arens · 2016 · Frontiers in Immunology
  91. Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
    Ethan Q Han, Xiuling Li, Chunrong Wang, Tian-Fang Li, Shuangyin Han · 2013 · Journal of Hematology & Oncology
  92. Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant
    Jennifer C. Massey, Ian J. Sutton, David D. F. Ma, John J. Moore · 2018 · Frontiers in Immunology
  93. Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy
    Ting Su, Furong Cheng, Jialong Qi, Yu Xin Zhang, Shurong Zhou, Lei Mei, Shiwei Fu, Fuwu Zhang, Shuibin Lin, Guizhi Zhu · 2022 · Advanced Science
  94. CD19‐Targeted chimeric antigen receptor‐modified T‐cell immunotherapy for B‐cell malignancies
    Cameron John Turtle, SR Riddell, David G. Maloney · 2016 · Clinical Pharmacology & Therapeutics
  95. CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical Success
    Kristen B. Long, Regina M. Young, Alina C. Boesteanu, Megan M. Suhoski, Jan Joseph Melenhorst, Simon Francis Lacey, David A. Degaramo, Bruce L. Levine, Joseph A. Fraietta · 2018 · Frontiers in Immunology
  96. Dysfunctional HIV-Specific CD8+ T Cell Proliferation Is Associated with Increased Caspase-8 Activity and Mediated by Necroptosis
    Gaurav D. Gaiha, Kevin J McKim, Matthew William Woods, Thomas Pertel, Janine Rohrbach, Natasha S. Barteneva, Christopher R. Chin, Dongfang Liu, Damien Z. Soghoian, Kevin T Cesa et al. · 2014 · Immunity
  97. Cells as advanced therapeutics: State-of-the-art, challenges, and opportunities in large scale biomanufacturing of high-quality cells for adoptive immunotherapies
    Nate Dwarshuis, Kirsten H. Parratt, Adriana N. Santiago-Miranda, Krishnendu Roy · 2017 · Advanced Drug Delivery Reviews
  98. Simultaneous Deletion of Endogenous TCRαβ for TCR Gene Therapy Creates an Improved and Safe Cellular Therapeutic
    Laura T. Morton, Rogier M. Reijmers, Anne K. Wouters, Christiaan Kweekel, Dennis F.G. Remst, Cilia R. Pothast, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk · 2019 · Molecular Therapy
  99. Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs
    André E. Nel, Kuo‐Ching Mei, Yu‐Pei Liao, Xiangsheng Liu · 2022 · ACS Nano
  100. TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu
    André Kunert, Trudy Straetemans, Coen Govers, Cor Lamers, Ron H.J. Mathijssen, Stefan Sleijfer, Reno Debets · 2013 · Frontiers in Immunology